Abstract
Background
A lucid dream is a dream in which one is aware of the fact that one is dreaming. Various cognitive and technical methods exist to induce lucid dreaming, most of which show only little success when tested scientifically. Until now, only few studies have dealt with inducing lucid dreaming by supplements, with, however, promising results.
Objective
We have continued this line of research by conducting a double-blind randomized placebo-controlled field study in order to investigate pharmacological lucid dream induction using L‑alpha-glycerylphosphorylcholine (α-GPC), a prescription-free drug acting as an acetylcholine precursor. Additionally, we tested whether cholinergic activation changes dream emotions or bizarreness.
Materials and methods
Following the baseline night with placebo, 23 participants with little lucid dreaming experience and 10 participants with advanced experience were administered a placebo on one night and 1200 mg of α‑GPC on one night. The Lucidity and Consciousness in Dreams (LuCiD) scale was used to measure the level of dream lucidity. In addition, dream reports were collected to analyse dream content alterations.
Results and conclusion
Out of 75 dreams in total, six were rated as lucid: two in the baseline condition, two in the placebo condition and two in the α‑GPC condition. There was no significant alteration of dream content such as dream emotions or bizarreness. Thus, previous anecdotal findings about lucidity-promoting or dream-altering effects of α‑GPC were not confirmed in our study.
Zusammenfassung
Hintergrund
Ein Klartraum ist ein Traum, in dem man sich der Tatsache bewusst ist, dass man träumt. Es gibt verschiedene kognitive und technische Verfahren, um Klarträume zu induzieren, jedoch sind die meisten davon in wissenschaftlichen Untersuchungen nur wenig erfolgreich. Bisher haben sich nur wenige Studien mit der Induktion von Klarträumen durch Präparate befasst, allerdings mit vielversprechenden Ergebnissen.
Ziel der Arbeit
Die Autoren haben diesen Forschungsansatz fortgeführt, indem sie eine doppelblinde randomisierte placebokontrollierte Feldstudie durchführten, um die pharmakologische Klartrauminduktion unter Einsatz von L‑alpha-Glycerylphosphorylcholin (α-GPC), einem rezeptfreien Nahrungsergänzungsmittel mit der Wirkung einer Vorstufe von Acetylcholin, zu untersuchen. Zusätzlich wurde untersucht, ob eine cholinerge Aktivierung die Traumemotionen oder die Skurrilität der Träume veränderte.
Material und Methoden
Nach der ersten Nacht als Ausgangswert mit Placebo wurde 23 Teilnehmern mit geringer Klartraumerfahrung und 10 Teilnehmern mit fortgeschrittener Erfahrung in der einen Nacht ein Placebo und in der anderen Nacht 1200 mg α‑GPC verabreicht. Zur Messung des Maßes der Traumluzidität wurde die Skala Lucidity and Consciousness in Dreams (LuCiD) verwendet. Darüber hinaus wurden Traumberichte erfasst, um Veränderung von Trauminhalten auszuwerten.
Ergebnisse und Schlussfolgerung
Von 75 Träumen insgesamt wurden 6 als Klartraum eingestuft: 2 in der Ausgangssituation, 2 in der Placebosituation und 2 in der α‑GPC-Situation. Es bestand keine wesentliche Abweichung der Trauminhalte in Bezug auf Traumemotionen oder -skurrilität. Somit wurden in der vorliegenden Studie anekdotische Angaben zur luziditätsfördernden oder traumverändernden Wirkung von α‑GPC nicht bestätigt.
Similar content being viewed by others
References
Agnew HW, Webb WB, Williams RL (1966) The first night effect: an EEG study of sleep. Psychophysiology 2:263–266. doi:10.1111/j.1469-8986.1966.tb02650.x
Carskadon MA, Dement WC et al (2005) Normal human sleep: an overview. Princ Pract Sleep Med 4:13–23. doi:10.1016/B978-1-4160-6645-3.00002-5
Dresler M, Wehrle R, Spoormaker VI et al (2012) Neural correlates of dream lucidity obtained from contrasting lucid versus non-lucid REM sleep: a combined EEG/fMRI case study. Sleep 35:1017–1020. doi:10.5665/sleep.1974
Görtelmeyer R (2011) SF-A/R und SF-B/R: Schlaffragebogen A und B. Hogrefe, Göttingen
Hobson JA (2009) REM sleep and dreaming: towards a theory of protoconsciousness. Nat Rev Neurosci 10:803–813. doi:10.1038/nrn2716
Hobson JA, McCarley RW (1977) The brain as a dream state generator: an activation-synthesis hypothesis of the dream process. Am J Psychiatry 134:1335–1348. doi:10.1176/ajp.134.12.1335
Hohagen F, Riemann D, Spiegel R et al (1993) Influence of the cholinergic agonist SDZ 210-086 on sleep in healthy subjects. Neuropsychopharmacology 9:225–232
LaBerge SP (1980) Lucid dreaming as a learnable skill: a case study. Percept Mot Skills 51:1039–1042
LaBerge SP (2003) Substances that enhance recall and lucidity during dreaming
LaBerge SP, Nagel LE, Dement WC et al (1981) Lucid dreaming verified by volitional communication during REM sleep. Percept Mot Skills 52:727–732. doi:10.2466/pms.1981.52.3.727
LaBerge S, Levitan L, Dement W (1986) Lucid dreaming: physiological correlates of consciousness during REM sleep. J Mind Behav 7:251–258
Mamelak AN, Hobson JA (1989) Dream bizarreness as the cognitive correlate of altered neuronal behavior in REM sleep. J Cogn Neurosci 1:201–222. doi:10.1162/jocn.1989.1.3.201
Nelson JP, McCarley RW, Hobson JA (1983) REM sleep burst neurons, PGO waves, and eye movement information. J Neurophysiol 50:784–797
Nissen C, Nofzinger EA, Feige B et al (2006) Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers. Neuropsychopharmacology 31:1294–1300. doi:10.1038/sj.npp.1300906
Sangiorgi G, Barbagallo M, Giordano M et al (1994) alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial. Ann N Y Acad Sci 717:253–269
Schredl M (2010) Dream content analysis: basic principles. Int J Dream Res 3:65–73
Schredl M, Erlacher D (2003) The problem of dream content analysis validity as shown by a bizarreness scale. Sleep Hypn 5:129–135
Schredl M, Erlacher D (2004) Lucid dreaming frequency and personality. Pers Individ Dif 37:1463–1473. doi:10.1016/j.paid.2004.02.003
Schredl M, Erlacher D (2011) Frequency of lucid dreaming in a representative German sample. Percept Mot Skills 112:104–108. doi:10.2466/09.PMS.112.1.104-108
Schürmann T, Weeß HG, Binder R et al (2001) Validierung des Landecker Inventar zur Erfassung von Schlafstörungen. Somnologie 5:50
Sitaram N, Moore AM, Gillin JC (1978) The effect of physostigmine on normal human sleep and dreaming. Arch Gen Psychiatry 35:1239–1243
Sitaram N, Moore AM, Gillin JC (1978) Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist. Nature 274:490–492. doi:10.1038/274490a0
Sparrow GS, Hurd R, Carlson R (2016) Assessing the perceived differences in post-Galantamine lucid dreams vs. non-Galantamine lucid dreams. Int J Dream Res 9:71–74. doi:10.11588/ijodr.2016.1.25606
Spiegel R (1984) Effects of RS 86, an orally active cholinergic agonist, on sleep in man. Psychiatry Res 11:1–13. doi:10.1016/0165-1781(84)90103-3
Stumbrys T, Erlacher D (2012) Lucid dreaming during NREM sleep: two case reports. Int J Dream Res 5:151–155. doi:10.11588/ijodr.2012.2.9483
Stumbrys T, Erlacher D (2016) Applications of lucid dreams and their effects on the mood upon awakening. Int J Dream Res 9:146–150. doi:10.11588/ijodr.2016.2.33114
Stumbrys T, Erlacher D, Schädlich M, Schredl M (2012) Induction of lucid dreams: a systematic review of evidence. Conscious Cogn 21:1456–1475. doi:10.1016/j.concog.2012.07.003
Voss U, Schermelleh-Engel K, Windt J et al (2013) Measuring consciousness in dreams: the lucidity and consciousness in dreams scale. Conscious Cogn 22:8–21. doi:10.1016/j.concog.2012.11.001
Yuschak T (2006) Advanced lucid dreaming, the power of supplements. Lulu Enterprises, Raleigh
Zadra AL, Donderi DC, Pihl RO (1992) Efficacy of lucid dream induction for lucid and non-lucid dreamers. Dreaming 2:85. doi:10.1037/h0094350
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
S. Kern, K. Appel, M. Schredl and G. Pipa declare that they have no competing interests.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Caption Electronic Supplementary Material
11818_2017_122_MOESM1_ESM.docx
1) A picture of the three different pills in use in this study with a coin as a size comparison 2) Extended results for all tables
Rights and permissions
About this article
Cite this article
Kern, S., Appel, K., Schredl, M. et al. No effect of α‑GPC on lucid dream induction or dream content. Somnologie 21, 180–186 (2017). https://doi.org/10.1007/s11818-017-0122-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11818-017-0122-8